FXN methylation predicts expression and clinical outcome in Friedreich ataxia
Marguerite V Evans-Galea, Nissa Carrodus, Simone M Rowley, Louise A Corben, Geneieve Tai, Richard Saffery, John C Galati, Nicholas C Wong, Jeffrey M Craig, David R Lynch, Sean R Regner, Alicia FD Brocht, Susan L Perlman, Khalaf O Bushara, Christopher M Gomez, George R Wilmot, Lingli Li, Elizabeth Varley, Martin B Delatycki, Joseph P Sarsero
Annals of Neurology | WILEY | Published : 2012
D.R.L., S. L. P., K.O.B., C. M. G., G. R. W., and M. B. D. are members of the Collaborative Clinical Research Network of Friedreich Ataxia (established and supported by the Friedreich Ataxia Research Alliance, USA).This study was supported by the National Health and Medical Council of Australia (Practitioner Fellowship to M. B. D.); the Friedreich Ataxia Research Alliance, USA (New Investigator Award to M.V.E.-G.); the Friedreich Ataxia Research Association, Australasia (M.V.E.-G., J.P.S and M. B. D.); the Australian Rotary Health Research Fund (M. V. E.-G., J.P.S and M. B. D.); the North Brighton Rotary Club (M. V. E.-G., J.P.S and M. B. D.); the Collier Charitable Fund of Australia (M. V. E.-G. and N.C.); the Victorian Government Operational Infrastructure Support Program; and the Muscular Dystrophy Association, USA (S.L.P.).D. R. L.: grants/grant pending, Santhera, Penwest/ENDO, Edison, MDA, NIH, FARA; patents, test for anti-NMDAR encephalitis; wife has served as a consultant for Biogen and Novartis (unrelated to present work). C. M. G.: grants/grants pending, speaking fees, travel expenses, Athena. M. B. D.: consultancy, Healthscope Pathology; grants/grants pending, National Health and Medical Research Council, FARA (USA), FARA (Australasia).